title: Authors' reply.
authors: W. Wolfgang Fleischhacker, Department of Psychiatry and Psychotherapy, Medical University Innsbruck, Austria. Email: wolfgang.fleischhacker@i-med.ac.at. Raymond Sanchez, MD, Otsuka Pharmaceutical Development & Commercialization, Princeton, USA.
authors: W Wolfgang
authors: WW
authors: Fleischhacker
authors: W. Wolfgang Fleischhacker, Department of Psychiatry and Psychotherapy, Medical University Innsbruck, Austria. Email: wolfgang.fleischhacker@i-med.ac.at. Raymond Sanchez, MD, Otsuka Pharmaceutical Development & Commercialization, Princeton, USA.
authors: Raymond
authors: R
authors: Sanchez
mesh_terms: D014150:Antipsychotic Agents / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D008297:Male; D010879:Piperazines / Q000008:administration & dosage*; D015363:Quinolones / Q000008:administration & dosage*; D012559:Schizophrenia / Q000188:drug therapy*
chemical_list: D014150:Antipsychotic Agents; D010879:Piperazines; D015363:Quinolones